C3.ai Inc. closed 52.06% short of its 52-week high of $45.08, which the company achieved on December 10th.

C3.ai's growth slowed last quarter, and that could be the start of a more troubling trend ahead. The business still isn't ...

Investors who bought $1,000 worth of C3.ai’s shares at the IPO in December 2020 would now be looking at an investment worth $295.28. Unless you’ve been living under a rock, it should be ...

Most of C3.ai's focus appears to be on driving sales through its partners, which now include McKinsey. Learn more about AI ...

C3.ai Inc. closed 53.59% below its 52-week high of $45.08, which the company reached on December 10th.

By the end of the month, C3.ai had lost 25%, according to S&P Global Market Intelligence. As you can see from the chart, the ...

C3.ai, Inc. is riding the AI coattails from Palantir Technologies, but the relative value is remarkable. The enterprise AI software company is focusing on AI pilot deals, with the expanded ...

Insilico Medicine Inc. is considering an initial public offering after securing funding at a valuation of more than $1 ...

C3.ai (NYSE: AI) has benefited significantly from the excitement surrounding artificial intelligence (AI). It provides companies in a wide range of industries with turnkey AI solutions ...

Shares of artificial intelligence (AI) software company C3.ai (NYSE:AI) fell 6.7% in the morning session as markets continued to struggle following the broad selloff triggered by weak economic ...